Ligand induced interaction of thyroid hormone receptor beta with its coregulators

Journal of Steroid Biochemistry and Molecular Biology

Volumn 112, Issue 4-5, 2008, Pages 205-212

  Valadares, Napoleão F ^a   Polikarpov, Igor ^a   Garratt, Richard C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

DAX1; GC 1; Kinetics; LBD; NH 3; SRC2; Surface plasmon resonance; Thyroid hormone receptor beta

Indexed keywords

THYROID HORMONE RECEPTOR BETA;

ARTICLE; KINETICS; PROTEIN ANALYSIS; PROTEIN INTERACTION; SURFACE PLASMON RESONANCE; THERMODYNAMICS;

AMINO ACID SEQUENCE; DNA-BINDING PROTEINS; HUMANS; KINETICS; LIGANDS; MODELS, MOLECULAR; NUCLEAR RECEPTOR COACTIVATOR 2; RECEPTORS, RETINOIC ACID; REPRESSOR PROTEINS; SURFACE PLASMON RESONANCE; THYROID HORMONE RECEPTORS BETA;

EID: 57449113796     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2008.10.006     Document Type: Article

References (44)

1. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science 240 4854 (1988) 889-895
2. Ribeiro R.C., Kushner P.J., and Baxter J.D. The nuclear hormone receptor gene superfamily. Annu. Rev. Med. 46 (1995) 443-453
3. Baxter J.D., Dillmann W.H., West B.L., Huber R., Furlow J.D., Fletterick R.J., Webb P., Apriletti J.W., and Scanlan T.S. Selective modulation of thyroid hormone receptor action. J. Steroid Biochem. Mol. Biol. 76 1-5 (2001) 31-42
4. Grover G.J., Mellström K., Ye L., Malm J., Li Y.L., Bladh L.G., Sleph P.G., Smith M.A., George R., Vennström B., Mookhtiar K., Horvath R., Speelman J., Egan D., and Baxter J.D. Selective thyroid hormone receptor-beta activation: a strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability. Proc. Natl. Acad. Sci. U. S. A. 100 17 (2003) 10067-10072
5. Baxter J.D., Webb P., Grover G., and Scanlan T.S. Selective activation of thyroid hormone signaling pathways by GC-1: a new approach to controlling cholesterol and body weight. Trends Endocrinol. Metab. 15 4 (2004) 154-157
6. Berkenstam A., Kristensen J., Mellström K., Carlsson B., Malm J., Rehnmark S., Garg N., Andersson C.M., Rudling M., Sjöberg F., Angelin B., and Baxter J.D. The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans. Proc. Natl. Acad. Sci. U. S. A. 105 2 (2008) 663-667
7. Bryzgalova G., Effendic S., Khan A., Rehnmark S., Barbounis P., Boulet J., Dong G., Singh R., Shapses S., Malm J., Webb P., Baxter J.D., and Grover G.J. Anti-obesity, anti-diabetic, and lipid lowering effects of the thyroid receptor beta subtype selective agonist KB-141. J. Steroid Biochem. Mol. Biol. 111 3-5 (2008) 262-267
8. Wagner R.L., Huber B.R., Shiau A.K., Kelly A., Cunha Lima S.T., Scanlan T.S., Apriletti J.W., Baxter J.D., West B.L., and Fletterick R.J. Hormone selectivity in thyroid hormone receptors. Mol. Endocrinol. 15 3 (2001) 398-410
9. Ye L., Li Y.L., Mellström K., Mellin C., Bladh L.G., Koehler K., Garg N., Garcia Collazo A.M., Litten C., Husman B., Persson K., Ljunggren J., Grover G., Sleph P.G., George R., and Malm J. Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor beta1. J. Med. Chem. 46 9 (2003) 1580-1588
10. Valadares N.F., Castilho M.S., Polikarpov I., and Garratt R.C. 2D QSAR studies on thyroid hormone receptor ligands. Bioorg. Med. Chem. 15 13 (2007) 4609-4617
11. Borngraeber S., Budny M.J., Chiellini G., Cunha Lima S.T., Togashi M., Webb P., Baxter J.D., Scanlan T.S., and Fletterick R.J. Ligand selectivity by seeking hydrophobicity in thyroid hormone receptor. Proc. Natl. Acad. Sci. U. S. A. 100 26 (2003) 15358-15363
12. Sandler B., Webb P., Apriletti J.W., Huber B.R., Togashi M., Cunha Lima S.T., Juric S., Nilsson S., Wagner R., Fletterick R.J., and Baxter J.D. Thyroxine-thyroid hormone receptor interactions. J. Biol. Chem. 279 53 (2004) 55801-55808
13. Nascimento A.S., Dias S.M., Nunes F.M., Aparício R., Ambrosio A.L., Bleicher L., Figueira A.C., Santos M.A., de Oliveira Neto M., Fischer H., Togashi M., Craievich A.F., Garratt R.C., Baxter J.D., Webb P., and Polikarpov I. Structural rearrangements in the thyroid hormone receptor hinge domain and their putative role in the receptor function. J. Mol. Biol. 360 3 (2006) 586-598
14. Darimont B.D., Wagner R.L., Apriletti J.W., Stallcup M.R., Kushner P.J., Baxter J.D., Fletterick R.J., and Yamamoto K.R. Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev. 12 21 (1998) 3343-3356
15. Leo C., and Chen J.D. The SRC family of nuclear receptor coactivators. Gene 245 1 (2000) 1-11
16. Xu J., and Li Q. Review of the in vivo functions of the p160 steroid receptor coactivator family. Mol. Endocrinol. 17 9 (2003) 1681-1692
17. Arnold L.A., Estébanez-Perpiñá E., Togashi M., Jouravel N., Shelat A., McReynolds A.C., Mar E., Nguyen P., Baxter J.D., Fletterick R.J., Webb P., and Guy R.K. Discovery of small molecule inhibitors of the interaction of the thyroid hormone receptor with transcriptional coregulators. J. Biol. Chem. 280 52 (2005) 43048-43055
18. Zanaria E., Muscatelli F., Bardoni B., Strom T.M., Guioli S., Guo W., Lalli E., Moser C., Walker A.P., and McCabe E.R. An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenital. Nature 372 6507 (1994) 635-641
19. Swain A., Zanaria E., Hacker A., Lovell-Badge R., and Camerino G. Mouse Dax1 expression is consistent with a role in sex determination as well as in adrenal and hypothalamus function. Nat. Genet. 12 4 (1996) 404-409
20. Ikeda Y., Takeda Y., Shikayama T., Mukai T., Hisano S., and Morohashi K.I. Comparative localization of Dax-1 and Ad4BP/SF-1 during development of the hypothalamic-pituitary-gonadal axis suggests their closely related and distinct functions. Dev. Dyn. 220 4 (2001) 363-376
21. Iyer A.K., and McCabe E.R. Molecular mechanisms of DAX1 action. Mol. Genet. Metab. 83 1-2 (2004) 60-73
22. McCabe E.R. DAX1: Increasing complexity in the roles of this novel nuclear receptor. Mol. Cell. Endocrinol. 265-266 (2007) 179-182
23. Niakan K.K., and McCabe E.R. DAX1 origin, function, and novel role. Mol. Genet. Metab. 86 1-2 (2005) 70-83
24. Moore J.M., Galicia S.J., McReynolds A.C., Nguyen N.H., Scanlan T.S., and Guy R.K. Quantitative proteomics of the thyroid hormone receptor-coregulator interactions. J. Biol. Chem. 279 26 (2004) 27584-27590
25. Wong C.W., Komm B., and Cheskis B.J. Structure-function evaluation of ER alpha and beta interplay with SRC family coactivators. ER selective ligands. Biochemistry 40 23 (2001) 6756-6765
26. Wärnmark A., Almlöf T., Leers J., Gustafsson J.A., and Treuter E. Differential recruitment of the mammalian mediator subunit TRAP220 by estrogen receptors ERalpha and ERbeta. J. Biol. Chem. 276 26 (2001) 23397-23404
27. Wärnmark A., Treuter E., Gustafsson J.A., Hubbard R.E., Brzozowski A.M., and Pike A.C. Interaction of transcriptional intermediary factor 2 nuclear receptor box peptides with the coactivator binding site of estrogen receptor alpha. J. Biol. Chem. 277 24 (2002) 21862-21868
28. Hur E., Pfaff S.J., Payne E.S., Gron H., Buehrer B.M., and Fletterick R.J. Recognition and accommodation at the androgen receptor coactivator binding interface. PLoS Biol. 2 9 (2004) E274
29. Zhao C., Toresson G., Xu L., Koehler K.F., Gustafsson J.A., and Dahlman-Wright K. Mouse estrogen receptor beta isoforms exhibit differences in ligand selectivity and coactivator recruitment. Biochemistry 44 22 (2005) 7936-7944
30. Bleicher L., Aparicio R., Nunes F.M., Martinez L., Gomes Dias S.M., Figueira A.C., Santos M.A., Venturelli W.H., da Silva R., Donate P.M., Neves F.A., Simeoni L.A., Baxter J.D., Webb P., Skaf M.S., and Polikarpov I. Structural basis of GC-1 selectivity for thyroid hormone receptor isoforms. BMC Struct. Biol. 8 8 (2008)
31. Nguyen N.H., Apriletti J.W., Cunha Lima S.T., Webb P., Baxter J.D., and Scanlan T.S. Rational design and synthesis of a novel thyroid hormone antagonist that blocks coactivator recruitment. J. Med. Chem. 45 15 (2002) 3310-3320
32. Myszka D.G. Kinetic analysis of macromolecular interactions using surface plasmon resonance biosensors. Curr. Opin. Biotechnol 8 1 (1997) 50-57
33. Lim W., Nguyen N.H., Yang H.Y., Scanlan T.S., and Furlow J.D. A thyroid hormone antagonist that inhibits thyroid hormone action in vivo. J. Biol. Chem. 277 38 (2002) 35664-35670
34. Myszka D.G. Improving biosensor analysis. J. Mol. Recognit. 12 5 (1999) 279-284
35. Lipschultz C.A., Li Y., and Smith-Gill S. Experimental design for analysis of complex kinetics using surface plasmon resonance. Methods 20 3 (2000) 310-318
36. Karlsson R., and Fält A. Experimental design for kinetic analysis of protein-protein interactions with surface plasmon resonance biosensors. J. Immunol. Methods 200 1-2 (1997) 121-133
37. Arnold L.A., Estébanez-Perpiñá E., Togashi M., Shelat A., Ocasio C.A., McReynolds A.C., Nguyen P., Baxter J.D., Fletterick R.J., Webb P., and Guy R.K. A high-throughput screening method to identify small molecule inhibitors of thyroid hormone receptor coactivator binding. Sci. STKE 341 (2006) pl3
38. Hangeland J.J., Doweyko A.M., Dejneka T., Friends T.J., Devasthale P., Mellström K., Sandberg J., Grynfarb M., Sack J.S., Einspahr H., Färnegårdh M., Husman B., Ljunggren J., Koehler K., Sheppard C., Malm J., and Ryono D.E. Thyroid receptor ligands. Part 2: Thyromimetics with improved selectivity for the thyroid hormone receptor beta. Bioorg. Med. Chem. Lett. 14 13 (2004) 3549-3553
39. Hassan A.Q., and Koh J.T. A functionally orthogonal ligand-receptor pair created by targeting the allosteric mechanism of the thyroid hormone receptor. J. Am. Chem. Soc. 128 27 (2006) 8868-8874
40. Webb P., Nguyen N.H., Chiellini G., Yoshihara H.A., Cunha Lima S.T., Apriletti J.W., Ribeiro R.C., Marimuthu A., West B.L., Goede P., Mellstrom K., Nilsson S., Kushner P.J., Fletterick R.J., Scanlan T.S., and Baxter J.D. Design of thyroid hormone receptor antagonists from first principles. J. Steroid Biochem. Mol. Biol. 83 1-5 (2002) 59-73
41. Ambrosio A.L., Dias S.M., Polikarpov I., Zurier R.B., Burstein S.H., and Garratt R.C. Ajulemic acid, a synthetic nonpsychoactive cannabinoid acid, bound to the ligand binding domain of the human peroxisome proliferator-activated receptor gamma. J. Biol. Chem. 282 25 (2007) 18625-18633
42. Estébanez-Perpiñá E., Arnold L.A., Nguyen P., Rodrigues E.D., Mar E., Bateman R., Pallai P., Shokat K.M., Baxter J.D., Guy R.K., Webb P., and Fletterick R.J. A surface on the androgen receptor that allosterically regulates coactivator binding. Proc. Natl. Acad. Sci. U. S. A. 104 41 (2007) 16074-16079
43. Figueira A.C., Dias S.M., Santos M.A., Apriletti J.W., Baxter J.D., Webb P., Neves F.A., Simeoni L.A., Ribeiro R.C., and Polikarpov I. Human thyroid receptor forms tetramers in solution, which dissociate into dimers upon ligand binding. Cell Biochem. Biophys. 44 3 (2006) 453-462
44. Estébanez-Perpiñá E., Arnold L.A., Jouravel N., Togashi M., Blethrow J., Mar E., Nguyen P., Phillips K.J., Baxter J.D., Webb P., Guy R.K., and Fletterick R.J. Structural insight into the mode of action of a direct inhibitor of coregulator binding to the thyroid hormone receptor. Mol. Endocrinol. 21 12 (2007) 2919-2928